Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-18T16:47:44.571Z Has data issue: false hasContentIssue false

9 - Constrained resources

Published online by Cambridge University Press:  05 October 2014

M. G. Myriam Hunink ,
Milton C. Weinstein ,
Eve Wittenberg ,
Michael F. Drummond ,
Joseph S. Pliskin ,
John B. Wong  and
Paul P. Glasziou
M. G. Myriam Hunink
Affiliation:
Erasmus Universiteit Rotterdam
Milton C. Weinstein
Affiliation:
Harvard University, Massachusetts
Eve Wittenberg
Affiliation:
Harvard School of Public Health, Massachusetts
Michael F. Drummond
Affiliation:
University of York
Joseph S. Pliskin
Affiliation:
Ben-Gurion University of the Negev, Israel
John B. Wong
Affiliation:
Tufts University, Massachusetts
Paul P. Glasziou
Affiliation:
Bond University, Queensland
Get access

Summary

There is no question that financial and medical effects will both be considered when making health care decisions at all levels of policymaking; the only question is whether they will be considered well.

Elaine J. Power and John M. Eisenberg

Introduction

Medical care entails benefits, harms, and costs. Until this chapter our approach has involved weighing benefits against harms for individuals and groups of patients and choosing the actions that provide the greatest expected health benefit. Now we extend our analysis to consider expressly the economic costs of health care and resource allocation decisions for populations.

As with all economic goods and services, the provision of health care consumes resources. Hospital beds, medical office facilities, medical equipment, pharmaceuticals, medical devices, and the time of physicians, nurses, other health-care workers, and family members all contribute to health care. The consumption of these resources constitutes the economic costs of health care.

Type
Chapter
Information
Decision Making in Health and Medicine
Integrating Evidence and Values
 , pp. 237 - 299
Publisher: Cambridge University Press
Print publication year: 2014

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Drummond, MF, Sculpher, MJ, Torrance, GW, O’Brien, BJ, Stoddart, GL. Methods for the Economic Evaluation of Health Care Programmes. 3rd edn. Oxford: Oxford University Press; 2005.Google Scholar
Tilling, C, Krol, M, Tsuchiya, A, Brazier, J, Brouwer, W. In or out? Income losses in health state valuations: a review. Value Health. 2010;13(2):298–305.CrossRefGoogle ScholarPubMed
Tilling, C, Krol, M, Tsuchiya, A, Brazier, J, van Exel, J, Brouwer, W. Does the EQ-5D reflect lost earnings?Pharmacoeconomics. 2012;30(1):47–61.CrossRefGoogle ScholarPubMed
National Institute for Health and Clinical Excellence (NICE). Guide to the Methods of Technology Appraisal. London: NICE; 2008.Google Scholar
Meltzer, D. Accounting for future costs in medical cost-effectiveness analysis. J Health Econ. 1997;16(1):33–64.CrossRefGoogle ScholarPubMed
Johannesson, M, Meltzer, D, O’Conor, RM. Incorporating future costs in medical cost-effectiveness analysis: Implications for the cost-effectiveness of the treatment of hypertension. Med Decis Making. 1997;17(4):382–9.CrossRefGoogle ScholarPubMed
Garber, AM, Phelps, CE. Economic foundations of cost-effectiveness analysis. J Health Econ. 1997;16(1):1–31.CrossRefGoogle ScholarPubMed
Kruse, M, Sorensen, J, Gyrd-Hansen, D. Future costs in cost-effectiveness analysis: an empirical assessment. Eur J Health Econ. 2012;13(1):63–70.CrossRefGoogle ScholarPubMed
Farnham, PG, Gorsky, RD, Holtgrave, DR, Jones, WK, Guinan, ME. Counseling and testing for HIV prevention: Costs, effects, and cost-effectiveness of more rapid screening tests. Public Health Reports. 1996;111(1):44–53.Google ScholarPubMed
Koopmanschap, MA, van Exel, JNA, van den Berg, B, Brouwer, WBF. An overview of methods and applications to value informal care in economic evaluations of healthcare. Pharmacoeconomics. 2008;26(4):269–80.CrossRefGoogle ScholarPubMed
Van den Berg, B, Ferrer-I-Carbonell, A. Monetary valuation of informal care: The well-being valuation method. Health Econ. 2007;16(11):1227–44.CrossRefGoogle ScholarPubMed
Koopmanschap, MA, Rutten, FFH, Vanineveld, BM, Vanroijen, L. The friction cost method for measuring indirect costs of disease. J Health Econ. 1995;14(2):171–89.CrossRefGoogle ScholarPubMed
Ware, JE, Sherbourne, CD. The Mos 36-Item Short-Form Health Survey (Sf-36).1. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.CrossRefGoogle ScholarPubMed
MacKenzie, EJ, Damiano, A, Miller, T, Luchter, S. The development of the Functional Capacity Index. J Trauma. 1996;41(5):799–807.CrossRefGoogle ScholarPubMed
Feeny, D, Furlong, W, Boyle, M, Torrance, GW. Multiattribute Health-Status Classification Systems – Health Utilities Index. Pharmacoeconomics. 1995;7(6):490–502.CrossRefGoogle Scholar
The EuroQol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.CrossRefGoogle Scholar
Kaplan, RM, Anderson, JP. A general health-policy model – update and applications. Health Services Research. 1988;23(2):203–35.Google ScholarPubMed
Brazier, J, Roberts, J, Deverill, M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271–92.CrossRefGoogle ScholarPubMed
Brazier, JE, Yang, YL, Tsuchiya, A, Rowen, DL. A review of studies mapping (or cross-walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ. 2010;11(2):215–25.CrossRefGoogle ScholarPubMed
Musgrove, P. Investing in health: the 1993 World Development Report of the World Bank. Bulletin of the Pan American Health Organization. 1993;27(3):284–6.Google ScholarPubMed
World Bank. World Development Report 1993: Investing in Health. Community Disease Report: Weekly. 1993;3:137.Google Scholar
Robberstad, B. QALYs vs. DALYs vs. LYs gained: What are the differences, and what difference do they make for health care priority setting?Norsk Epidemiologi. 2005;15(2):183–99.Google Scholar
Murray, CJL, Lopez, AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349(9063):1436–42.CrossRefGoogle ScholarPubMed
Murray, CJL, Lopez, AD. Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: Global Burden of Disease Study. Lancet. 1997;349(9062):1347–52.CrossRefGoogle ScholarPubMed
Edejer, TT-T. Making Choices in Health: WHO Guide to Cost-effectiveness Analysis. Geneva: World Health Organization; 2004.Google Scholar
Craig, BM, Busschbach, JJ, Salomon, JA. Modeling ranking, time trade-off, and visual analog scale values for EQ-5D health states: a review and comparison of methods. Med Care. 2009;47(6):634–41.CrossRefGoogle ScholarPubMed
Craig, BM, Busschbach, JJ, Salomon, JA. Keep it simple: ranking health states yields values similar to cardinal measurement approaches. J Clin Epidemiol. 2009;62(3):296–305.CrossRefGoogle ScholarPubMed
Rushby, JF, Hanson, K. Calculating and presenting disability-adjusted life-years (DALYs) in cost-effectiveness analysis. Health Policy Plan. 2001;16(3):326–31.CrossRefGoogle Scholar
Airoldi, M, Morton, A. Adjusting life for quality or disability: stylistic difference or substantial dispute?Health Econ. 2009;18(11):1237–47.CrossRefGoogle ScholarPubMed
Chapman, GB, Elstein, AS. Valuing the future – temporal discounting of health and money. Med Decis Making. 1995;15(4):373–86.CrossRefGoogle ScholarPubMed
Lipscomb, J. Time preference. In Gold, MR, Siegel, JE, Russell, LB, Weinstein, MC, eds. Cost-effectiveness in Health and Medicine. USA: Oxford University Press; 1996. pp. 214–46.Google Scholar
Redelmeier, DA, Heller, DN. Time preference in medical decision-making and cost-effectiveness analysis. Med Decis Making. 1993;13(3):212–17.CrossRefGoogle ScholarPubMed
Keeler, EB, Cretin, S. Discounting of life-saving and other non-monetary effects. Manage Sci. 1983;29(3):300–6.CrossRefGoogle Scholar
Weinstein, MC, Stason, WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977;296(13):716–21.CrossRefGoogle ScholarPubMed
Gravelle, H, Smith, D. Discounting for health effects in cost-benefit and cost-effectiveness analysis. Health Econ. 2001;10(7):587–99.CrossRefGoogle ScholarPubMed
Claxton, K, Paulden, M, Gravelle, H, Brouwer, W, Culyer, AJ. Discounting and decision making in the economic evaluation of health-care technologies. Health Econ. 2011;20(1):2–15.CrossRefGoogle ScholarPubMed
Gold, MR, Siegel, JE, Russell, LB, Weinstein, MC. Cost-Effectiveness in Health and Medicine. USA: Oxford University Press; 1996.Google Scholar
College voor zorgverzekeringen (CvZ). Guidelines for Pharmacoeconomic Research, updated version. 2006 [cited 2012 18 August]; available from: .
Brown, ML, Fintor, L. Cost-effectiveness of breast-cancer screening – preliminary results of a systematic review of the literature. Breast Cancer Res Treat. 1993;25(2):113–18.CrossRefGoogle ScholarPubMed
Centre for Reviews and Dissemination. NHS EED. York: University of York; 2012 [cited 2012 18 August]; available from: .Google Scholar
Tufts Medical Center. Cost-effectiveness analysis registry. 2012 [cited 2012 18 August]; Available from: .
Griffin, S, Claxton, K, Hawkins, N, Sculpher, M. Probabilistic analysis and computationally expensive models: Necessary and required?Value Health. 2006;9(4):244–52.CrossRefGoogle ScholarPubMed
Russell, LB, Gold, MR, Siegel, JE, Daniels, N, Weinstein, MC. The role of cost-effectiveness analysis in health and medicine. JAMA. 1996;276(14):1172–7.CrossRefGoogle Scholar
Siegel, JE, Weinstein, MC, Russell, LB, Gold, MR. Recommendations for reporting cost-effectiveness analyses. JAMA. 1996;276(16):1339–41.CrossRefGoogle ScholarPubMed
Weinstein, MC, Siegel, JE, Gold, MR, Kamlet, MS, Russell, LB. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA. 1996;276(15):1253–8.CrossRefGoogle ScholarPubMed
Canadian Agency for Drugs and Technologies in Health. Guidelines for the Economic Evaluation of Health Technologies. Ottawa, Canada: CADTH; 2006.Google Scholar
The BMJ Economic Evaluation Working Party. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ. 1996;313(7052):275–83.CrossRefGoogle Scholar
FMCP Format Executive Committee. The AMCP Format for Formulary Submissions. Alexandria, VA: AMCP; 2009 [cited 2012 18 August]; 3.0:[available from: ].Google Scholar
International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Pharmacoeconomic Guidelines Around The World. USA: ISPOR; 2012 [cited 2012 18 August]; available from: .Google Scholar
Sculpher, MJ, Pang, FS, Manca, A, et al. Generalisability in economic evaluation studies in healthcare: a review and case studies. Health Technol Assess. 2004;8(49).CrossRefGoogle ScholarPubMed
Barbieri, M, Drummond, MF, Rutten, F, et al. ISPOR Good Research Practices Economic Data Transferability Task Force: What do international pharmacoeconomic guidelines say about economic data transferability?Value Health. 2010;13(8):1028–37.CrossRefGoogle ScholarPubMed
Drummond, MF, Barbieri, M, Cook, J, et al. Transferability of Economic Evaluations Across Jurisdictions: ISPOR Good Research Practices Task Force Report. Value Health. 2009;12(4):409–18.CrossRefGoogle ScholarPubMed
Chambers, JD, Morris, S, Neumann, PJ, Buxton, MJ. Factors predicting Medicare national coverage: an empirical analysis. Med Care. 2012;50(3):249–56.CrossRefGoogle ScholarPubMed
Neumann, PJ. Using Cost-effectiveness Analysis to Improve Health Care: Opportunities and Barriers. USA: Oxford University Press; 2004.CrossRefGoogle Scholar
Sampat, B, Drummond, MF. Another special relationship? Interactions between health technology policies and health care systems in the United States and the United Kingdom. Journal of Health Politics, Policy and Law. 2011;36(1):119–39.CrossRefGoogle ScholarPubMed
Rawlins, MD, Culyer, AJ. National Institute for Clinical Excellence and its value judgments. BMJ. 2004;329(7459):224–7.CrossRefGoogle ScholarPubMed
Mason, AR, Drummond, MF. Public funding of new cancer drugs: Is NICE getting nastier?Eur J Cancer Clin Oncol. 2009;45(7):1188–92.Google ScholarPubMed
George, B, Harris, A, Mitchell, A. Cost effectiveness analysis and the consistency of decision making – evidence from pharmaceutical reimbursement in Australia (1991 to 1996). Pharmacoeconomics. 2001;19(11):1103–9.CrossRefGoogle Scholar
Drummond, MF. Twenty Years of Using Economic Evaluations for Reimbursement Decisions. What Have We Achieved?University of York, York: Centre for Health Economics 2012. Research Paper No. 75.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×